We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Ebolavirus Nucleoprotein Suggested as Possible Drug Target

By LabMedica International staff writers
Posted on 19 Apr 2015
Print article
Image: A protein — shown in red, white, and blue — typically coats the genome of the Ebolavirus, providing protection from enzymes that can destroy the virus’s genetic material. This protein coat is removed to allow the virus to replicate its genome in infected cells. Interfering with the removal and the return of the protein coat to the viral genome can kill the Ebola virus, a discovery that opens the door to more effective treatments (Photo courtesy of Washington University School of Medicine).
Image: A protein — shown in red, white, and blue — typically coats the genome of the Ebolavirus, providing protection from enzymes that can destroy the virus’s genetic material. This protein coat is removed to allow the virus to replicate its genome in infected cells. Interfering with the removal and the return of the protein coat to the viral genome can kill the Ebola virus, a discovery that opens the door to more effective treatments (Photo courtesy of Washington University School of Medicine).
A team of molecular virologists has isolated and characterized a peptide from Ebolavirus (EBOV) that is critical to the pathogen's ability to reproduce inside infected cells.

Ebola is an RNA virus whose nucleic acid package is covered with a protective nucleoprotein (NP) coat. NP alternates between an RNA-template-bound form and a template-free form to provide the viral polymerase access to the RNA template. In addition, newly synthesized NP must be prevented from indiscriminately binding to nonviral RNAs.

Investigators at the Washington University School of Medicine (St. Louis, MO, USA) have explained the molecular bases for these critical processes in a paper published in the April 9, 2015, online edition of the journal Cell Reports. They reported the identification of an intrinsically disordered peptide derived from EBOV VP35 nucleoprotein (NPBP, residues 20–48) that bound to NP with high affinity and specificity, inhibited NP oligomerization, and released RNA from NP-RNA complexes in vitro.

X-ray crystallography analysis at a resolution of 3.7 Angstroms revealed that NPBP peptide occluded a large surface area that was important for NP-NP and NP-RNA interactions and for viral RNA synthesis. This peptide represented a highly conserved viral interface that was important for EBOV replication and could be targeted for therapeutic development.

“One of the major challenges was that the part of VP35 involved in this interaction is an intrinsically disordered peptide,” said first author Dr. Daisy Leung, assistant professor of pathology and immunology at Washington University Medical School. “This means that it may not take on a definite structure until it binds to another protein. That made structural studies of VP35 difficult because the structure, which plays a critical role in determining function, does not form without its specific binding partner.”

Related Links:

Washington University School of Medicine


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.